

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 9.50846211 |
| 2 | macrophage activation involved in immune response (GO:0002281) | 8.29530328 |
| 3 | positive regulation of chemokine secretion (GO:0090197) | 7.54526381 |
| 4 | chondroitin sulfate catabolic process (GO:0030207) | 7.06832469 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 6.82361055 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 6.71213946 |
| 7 | phosphatidylglycerol biosynthetic process (GO:0006655) | 6.16241969 |
| 8 | macrophage activation (GO:0042116) | 6.10889120 |
| 9 | * G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 6.06178962 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 6.04414413 |
| 11 | glycolipid catabolic process (GO:0019377) | 6.03822215 |
| 12 | thrombin receptor signaling pathway (GO:0070493) | 5.83750469 |
| 13 | regulation of chemokine secretion (GO:0090196) | 5.70444861 |
| 14 | negative regulation of multicellular organism growth (GO:0040015) | 5.65781272 |
| 15 | ceramide catabolic process (GO:0046514) | 5.56669714 |
| 16 | macrophage chemotaxis (GO:0048246) | 5.38398636 |
| 17 | * purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.38351351 |
| 18 | keratan sulfate catabolic process (GO:0042340) | 5.30940596 |
| 19 | phenylpropanoid metabolic process (GO:0009698) | 5.22978883 |
| 20 | protein neddylation (GO:0045116) | 5.19321644 |
| 21 | negative regulation of granulocyte differentiation (GO:0030853) | 5.11276208 |
| 22 | regulation of platelet activation (GO:0010543) | 5.10420635 |
| 23 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 5.04832667 |
| 24 | positive regulation of mast cell activation (GO:0033005) | 4.99920805 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.99609774 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.98855866 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.95207319 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.94205794 |
| 29 | adaptation of signaling pathway (GO:0023058) | 4.80946046 |
| 30 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.72012977 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.64037610 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.64037610 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 4.64037610 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 4.64037610 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 4.64037610 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.64037610 |
| 37 | hyaluronan catabolic process (GO:0030214) | 4.49517879 |
| 38 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.43730755 |
| 39 | regulation of hypersensitivity (GO:0002883) | 4.39071054 |
| 40 | cyclooxygenase pathway (GO:0019371) | 4.37110777 |
| 41 | negative regulation of smooth muscle contraction (GO:0045986) | 4.28879247 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.28203510 |
| 43 | * purinergic receptor signaling pathway (GO:0035587) | 4.26428859 |
| 44 | blood coagulation, intrinsic pathway (GO:0007597) | 4.24754484 |
| 45 | negative regulation of platelet activation (GO:0010544) | 4.22263629 |
| 46 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.18387779 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 4.06018701 |
| 48 | lytic vacuole organization (GO:0080171) | 4.05812420 |
| 49 | lysosome organization (GO:0007040) | 4.05812420 |
| 50 | ruffle organization (GO:0031529) | 4.05640472 |
| 51 | Rac protein signal transduction (GO:0016601) | 4.02920203 |
| 52 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.02737888 |
| 53 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.99922608 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.85002731 |
| 55 | ganglioside metabolic process (GO:0001573) | 3.83584307 |
| 56 | positive regulation of mast cell degranulation (GO:0043306) | 3.77773304 |
| 57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.77773304 |
| 58 | neutrophil activation (GO:0042119) | 3.76346340 |
| 59 | angiogenesis involved in wound healing (GO:0060055) | 3.72264109 |
| 60 | glial cell migration (GO:0008347) | 3.71539059 |
| 61 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.71326436 |
| 62 | tolerance induction (GO:0002507) | 3.64098867 |
| 63 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.59058693 |
| 64 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.56350823 |
| 65 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.55758654 |
| 66 | response to host (GO:0075136) | 3.55559195 |
| 67 | response to host defenses (GO:0052200) | 3.55559195 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55559195 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.54199962 |
| 70 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.54199962 |
| 71 | sodium-independent organic anion transport (GO:0043252) | 3.53994129 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53563343 |
| 73 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.51860449 |
| 74 | * platelet aggregation (GO:0070527) | 3.49024939 |
| 75 | megakaryocyte development (GO:0035855) | 3.48890908 |
| 76 | regulation of macrophage chemotaxis (GO:0010758) | 3.45765145 |
| 77 | regulation of lipoprotein metabolic process (GO:0050746) | 3.45152952 |
| 78 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.45054569 |
| 79 | oligosaccharide metabolic process (GO:0009311) | 3.44574636 |
| 80 | outer ear morphogenesis (GO:0042473) | 3.41763941 |
| 81 | lipoxygenase pathway (GO:0019372) | 3.41332534 |
| 82 | granulocyte activation (GO:0036230) | 3.35439821 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 3.34850593 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.33777335 |
| 85 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.33521392 |
| 86 | nucleoside diphosphate catabolic process (GO:0009134) | 3.33339583 |
| 87 | regulation of interferon-alpha production (GO:0032647) | 3.31875465 |
| 88 | adrenergic receptor signaling pathway (GO:0071875) | 3.31609919 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31171243 |
| 90 | positive regulation of interferon-alpha production (GO:0032727) | 3.31168563 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 3.30321586 |
| 92 | regulation of mast cell activation (GO:0033003) | 3.30193678 |
| 93 | platelet formation (GO:0030220) | 3.28216681 |
| 94 | regulation of integrin activation (GO:0033623) | 3.25588556 |
| 95 | monocyte differentiation (GO:0030224) | 3.23493448 |
| 96 | negative regulation of muscle contraction (GO:0045932) | 3.23047892 |
| 97 | negative regulation of heart rate (GO:0010459) | 3.22910926 |
| 98 | positive regulation of B cell mediated immunity (GO:0002714) | 3.21871980 |
| 99 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.21871980 |
| 100 | * adenosine receptor signaling pathway (GO:0001973) | 3.21239039 |
| 101 | platelet degranulation (GO:0002576) | 3.21205549 |
| 102 | positive regulation of microtubule polymerization (GO:0031116) | 3.18354882 |
| 103 | positive regulation of receptor recycling (GO:0001921) | 3.17227334 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 3.11985877 |
| 105 | phagocytosis, engulfment (GO:0006911) | 3.11008134 |
| 106 | histamine secretion (GO:0001821) | 3.10291210 |
| 107 | I-kappaB phosphorylation (GO:0007252) | 3.08234070 |
| 108 | negative regulation of tissue remodeling (GO:0034104) | 3.08228045 |
| 109 | sphingolipid catabolic process (GO:0030149) | 3.08048710 |
| 110 | * platelet activation (GO:0030168) | 3.07399919 |
| 111 | negative regulation of heart contraction (GO:0045822) | 3.07209637 |
| 112 | regulation of T cell tolerance induction (GO:0002664) | 3.06491940 |
| 113 | negative regulation of interleukin-6 production (GO:0032715) | 3.05848527 |
| 114 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.03609515 |
| 115 | regulation of mast cell degranulation (GO:0043304) | 3.03104724 |
| 116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.01026224 |
| 117 | negative regulation of interleukin-17 production (GO:0032700) | 3.00255544 |
| 118 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98524346 |
| 119 | membrane invagination (GO:0010324) | 2.98093981 |
| 120 | phagocytosis, recognition (GO:0006910) | 2.97505616 |
| 121 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.95412439 |
| 122 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.94174830 |
| 123 | negative regulation of protein localization to cell surface (GO:2000009) | 2.94082837 |
| 124 | cellular response to fluid shear stress (GO:0071498) | 2.93760966 |
| 125 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93682429 |
| 126 | negative regulation of B cell proliferation (GO:0030889) | 2.93625198 |
| 127 | regulation of monocyte chemotaxis (GO:0090025) | 2.92883263 |
| 128 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.92404112 |
| 129 | myeloid leukocyte activation (GO:0002274) | 2.91292377 |
| 130 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.89698187 |
| 131 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.88873320 |
| 132 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.86663017 |
| 133 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.86522509 |
| 134 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86131769 |
| 135 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85504820 |
| 136 | response to host immune response (GO:0052572) | 2.85504820 |
| 137 | positive regulation of hemostasis (GO:1900048) | 2.80265776 |
| 138 | positive regulation of blood coagulation (GO:0030194) | 2.80265776 |
| 139 | regulation of female receptivity (GO:0045924) | 2.79399357 |
| 140 | positive regulation of muscle hypertrophy (GO:0014742) | 2.78743046 |
| 141 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.78743046 |
| 142 | activated T cell proliferation (GO:0050798) | 2.78471830 |
| 143 | mannose metabolic process (GO:0006013) | 2.78408141 |
| 144 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.78153857 |
| 145 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.78153857 |
| 146 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.78153857 |
| 147 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.77945096 |
| 148 | regulation of alkaline phosphatase activity (GO:0010692) | 2.77372025 |
| 149 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.76928587 |
| 150 | response to muramyl dipeptide (GO:0032495) | 2.76869962 |
| 151 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.76801691 |
| 152 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.75771025 |
| 153 | leukocyte degranulation (GO:0043299) | 2.75568695 |
| 154 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.75390404 |
| 155 | negative regulation of response to food (GO:0032096) | 2.75208508 |
| 156 | negative regulation of appetite (GO:0032099) | 2.75208508 |
| 157 | reverse cholesterol transport (GO:0043691) | 2.74642338 |
| 158 | membrane lipid catabolic process (GO:0046466) | 2.73374020 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72815146 |
| 160 | regulation of platelet aggregation (GO:0090330) | 2.71271127 |
| 161 | cellular response to ethanol (GO:0071361) | 2.70065652 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.69900390 |
| 163 | actin filament polymerization (GO:0030041) | 2.69557234 |
| 164 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.69456422 |
| 165 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.69048366 |
| 166 | multicellular organismal reproductive behavior (GO:0033057) | 2.68578899 |
| 167 | regulation of B cell differentiation (GO:0045577) | 2.68365766 |
| 168 | oogenesis (GO:0048477) | 2.68075089 |
| 169 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.67348925 |
| 170 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66687471 |
| 171 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.66190159 |
| 172 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.65589559 |
| 173 | polyamine biosynthetic process (GO:0006596) | 2.65268800 |
| 174 | cell-cell junction maintenance (GO:0045217) | 2.65173514 |
| 175 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.64822251 |
| 176 | regulation of leukocyte degranulation (GO:0043300) | 2.64746545 |
| 177 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.63972090 |
| 178 | prostaglandin metabolic process (GO:0006693) | 2.63738024 |
| 179 | prostanoid metabolic process (GO:0006692) | 2.63738024 |
| 180 | negative regulation of bone resorption (GO:0045779) | 2.62909170 |
| 181 | response to cholesterol (GO:0070723) | 2.62283591 |
| 182 | phagocytosis (GO:0006909) | 2.62181464 |
| 183 | termination of signal transduction (GO:0023021) | 2.61558834 |
| 184 | positive regulation of Rap GTPase activity (GO:0032854) | 2.61141838 |
| 185 | high-density lipoprotein particle remodeling (GO:0034375) | 2.61060281 |
| 186 | microglial cell activation (GO:0001774) | 11.9778127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.13745722 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.78395939 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.00946313 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77164323 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.25092805 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.14659283 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11401146 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.05134550 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.03517288 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.88439702 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71437763 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.71179844 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65638504 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41509411 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19953060 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.17728231 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.16911822 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14645839 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09436043 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06766836 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00507356 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98799997 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89175486 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85819712 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73030594 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.72380572 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66361515 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62924933 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59383947 |
| 30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56754241 |
| 31 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53347517 |
| 32 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.48542819 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47067261 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46596202 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46442999 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45494570 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44890803 |
| 38 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42393576 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41620412 |
| 40 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39553299 |
| 41 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.38236607 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34051540 |
| 43 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.33750709 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30338087 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28662691 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28281010 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26976783 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24592744 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24495323 |
| 50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.23633385 |
| 51 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22633180 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22619083 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22592170 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18830696 |
| 55 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18586665 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18490695 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18346101 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18114296 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17954085 |
| 60 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.17630803 |
| 61 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17440327 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16177844 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15901631 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14587497 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13998982 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13958717 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13958717 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12351991 |
| 69 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.12351878 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11832594 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11212040 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11054358 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10405963 |
| 74 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09472564 |
| 75 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09472564 |
| 76 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09472564 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06685088 |
| 78 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02936591 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01620389 |
| 80 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.00495178 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98611500 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98349570 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97591953 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97187591 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95948632 |
| 86 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95373984 |
| 87 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95273770 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93891470 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93562900 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91851236 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91659352 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91333770 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 0.90325071 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90103208 |
| 95 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.89927876 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89683558 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89571726 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89571726 |
| 99 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88871392 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88844066 |
| 101 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88695164 |
| 102 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88423616 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88186829 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87308905 |
| 105 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.86986790 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86929468 |
| 107 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86176491 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85343983 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84961648 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.84195836 |
| 111 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83748120 |
| 112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83701181 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83525221 |
| 114 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82625691 |
| 115 | MYB_26560356_Chip-Seq_TH2_Human | 0.82428060 |
| 116 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82051920 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81915956 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81700832 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80475987 |
| 120 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79951057 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79804222 |
| 122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79523100 |
| 123 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.79062986 |
| 124 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78800634 |
| 125 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77587768 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77054213 |
| 127 | AR_25329375_ChIP-Seq_VCAP_Human | 0.76874149 |
| 128 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76621438 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76418223 |
| 130 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76398511 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.76338009 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76070284 |
| 133 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.75956095 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75744357 |
| 135 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75671001 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75005856 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.74575699 |
| 138 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.74425356 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73508710 |
| 140 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.72836384 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.71818511 |
| 142 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.71045301 |
| 143 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70688863 |
| 144 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70099546 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.69986626 |
| 146 | MYB_26560356_Chip-Seq_TH1_Human | 0.69947997 |
| 147 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.69775414 |
| 148 | UTX_26944678_Chip-Seq_JUKART_Human | 0.69680833 |
| 149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68760308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 6.95002429 |
| 2 | MP0006082_CNS_inflammation | 6.53687585 |
| 3 | MP0005058_abnormal_lysosome_morphology | 5.11289023 |
| 4 | MP0003690_abnormal_glial_cell | 4.90693286 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.81644056 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.31384295 |
| 7 | MP0004883_abnormal_blood_vessel | 3.21704593 |
| 8 | MP0005671_abnormal_response_to | 3.19232111 |
| 9 | MP0003075_altered_response_to | 2.84183036 |
| 10 | MP0003303_peritoneal_inflammation | 2.74758067 |
| 11 | MP0003252_abnormal_bile_duct | 2.63377135 |
| 12 | * MP0005464_abnormal_platelet_physiology | 2.37562381 |
| 13 | MP0009384_cardiac_valve_regurgitation | 2.36641398 |
| 14 | MP0008004_abnormal_stomach_pH | 2.25347881 |
| 15 | MP0003045_fibrosis | 2.15347863 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.14830966 |
| 17 | MP0002419_abnormal_innate_immunity | 1.98838026 |
| 18 | MP0001545_abnormal_hematopoietic_system | 1.96340801 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.96340801 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.93343971 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.89719892 |
| 22 | MP0004130_abnormal_muscle_cell | 1.83868284 |
| 23 | MP0005166_decreased_susceptibility_to | 1.83550030 |
| 24 | MP0005164_abnormal_response_to | 1.72079846 |
| 25 | MP0009840_abnormal_foam_cell | 1.70800863 |
| 26 | MP0001851_eye_inflammation | 1.70382379 |
| 27 | MP0009278_abnormal_bone_marrow | 1.69752039 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.68763790 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.64792822 |
| 30 | MP0003879_abnormal_hair_cell | 1.63212043 |
| 31 | MP0000685_abnormal_immune_system | 1.58640616 |
| 32 | MP0005387_immune_system_phenotype | 1.54493781 |
| 33 | MP0001790_abnormal_immune_system | 1.54493781 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.50946323 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.50033634 |
| 36 | MP0000920_abnormal_myelination | 1.49253443 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.47729467 |
| 38 | MP0001915_intracranial_hemorrhage | 1.46823512 |
| 39 | MP0008007_abnormal_cellular_replicative | 1.45647491 |
| 40 | MP0005670_abnormal_white_adipose | 1.43498069 |
| 41 | MP0002723_abnormal_immune_serum | 1.40174967 |
| 42 | MP0002090_abnormal_vision | 1.36712143 |
| 43 | MP0003638_abnormal_response/metabolism_ | 1.35011901 |
| 44 | MP0000249_abnormal_blood_vessel | 1.34016404 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.33527942 |
| 46 | MP0003724_increased_susceptibility_to | 1.30778791 |
| 47 | MP0004947_skin_inflammation | 1.30552920 |
| 48 | MP0003436_decreased_susceptibility_to | 1.28818210 |
| 49 | MP0009763_increased_sensitivity_to | 1.27616322 |
| 50 | MP0001819_abnormal_immune_cell | 1.27480153 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.27130416 |
| 52 | MP0005083_abnormal_biliary_tract | 1.25470221 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.25007309 |
| 54 | MP0001800_abnormal_humoral_immune | 1.24626070 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.23795727 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.23490457 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.21908256 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.21393948 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.20878843 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.20539354 |
| 61 | MP0002254_reproductive_system_inflammat | 1.20288659 |
| 62 | MP0009785_altered_susceptibility_to | 1.18251829 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.15032574 |
| 64 | MP0008874_decreased_physiological_sensi | 1.14423019 |
| 65 | MP0008469_abnormal_protein_level | 1.12054641 |
| 66 | MP0001663_abnormal_digestive_system | 1.11813867 |
| 67 | MP0003866_abnormal_defecation | 1.10650248 |
| 68 | MP0000343_altered_response_to | 1.10438496 |
| 69 | MP0005165_increased_susceptibility_to | 1.10234361 |
| 70 | MP0004484_altered_response_of | 1.08917782 |
| 71 | MP0003195_calcinosis | 1.08571806 |
| 72 | MP0009764_decreased_sensitivity_to | 1.08379106 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.06146502 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.05959254 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.05169564 |
| 76 | MP0009053_abnormal_anal_canal | 1.02691166 |
| 77 | MP0001970_abnormal_pain_threshold | 1.02508777 |
| 78 | MP0005171_absent_coat_pigmentation | 1.01703936 |
| 79 | MP0003634_abnormal_glial_cell | 1.01451239 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.00995921 |
| 81 | MP0002928_abnormal_bile_duct | 1.00110569 |
| 82 | MP0004270_analgesia | 0.99425430 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.99124500 |
| 84 | MP0006138_congestive_heart_failure | 0.99020083 |
| 85 | MP0005025_abnormal_response_to | 0.98155048 |
| 86 | MP0000858_altered_metastatic_potential | 0.97898475 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.95153368 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.93634917 |
| 89 | MP0003279_aneurysm | 0.90851658 |
| 90 | MP0003828_pulmonary_edema | 0.90280098 |
| 91 | MP0003329_amyloid_beta_deposits | 0.89691630 |
| 92 | MP0003633_abnormal_nervous_system | 0.89484097 |
| 93 | MP0008873_increased_physiological_sensi | 0.88061271 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.87505048 |
| 95 | MP0000716_abnormal_immune_system | 0.84559728 |
| 96 | MP0002736_abnormal_nociception_after | 0.83196947 |
| 97 | MP0006276_abnormal_autonomic_nervous | 0.81892203 |
| 98 | MP0005023_abnormal_wound_healing | 0.80787606 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.80153985 |
| 100 | MP0005410_abnormal_fertilization | 0.77603425 |
| 101 | MP0005535_abnormal_body_temperature | 0.77402860 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.77290056 |
| 103 | MP0003091_abnormal_cell_migration | 0.76453237 |
| 104 | MP0001661_extended_life_span | 0.76354506 |
| 105 | MP0001873_stomach_inflammation | 0.76283640 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.75480204 |
| 107 | MP0004510_myositis | 0.74472361 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.73850874 |
| 109 | MP0005197_abnormal_uvea_morphology | 0.73218074 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.71709842 |
| 111 | MP0002971_abnormal_brown_adipose | 0.71084331 |
| 112 | MP0002735_abnormal_chemical_nociception | 0.70221089 |
| 113 | MP0001764_abnormal_homeostasis | 0.68925206 |
| 114 | MP0005310_abnormal_salivary_gland | 0.68013716 |
| 115 | MP0005647_abnormal_sex_gland | 0.67786782 |
| 116 | * MP0009642_abnormal_blood_homeostasis | 0.66174863 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.65643974 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.65384331 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.65236958 |
| 120 | MP0002933_joint_inflammation | 0.64913785 |
| 121 | MP0003136_yellow_coat_color | 0.64692193 |
| 122 | MP0004859_abnormal_synaptic_plasticity | 0.64274568 |
| 123 | MP0002429_abnormal_blood_cell | 0.64150864 |
| 124 | MP0003795_abnormal_bone_structure | 0.63755273 |
| 125 | MP0002064_seizures | 0.62292917 |
| 126 | MP0002722_abnormal_immune_system | 0.61853332 |
| 127 | MP0000609_abnormal_liver_physiology | 0.61283582 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.61146521 |
| 129 | MP0002405_respiratory_system_inflammati | 0.60073076 |
| 130 | MP0002398_abnormal_bone_marrow | 0.59031821 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.57397386 |
| 132 | MP0001849_ear_inflammation | 0.57275995 |
| 133 | MP0002396_abnormal_hematopoietic_system | 0.55757231 |
| 134 | MP0002229_neurodegeneration | 0.55031654 |
| 135 | MP0005409_darkened_coat_color | 0.52926937 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.52728204 |
| 137 | MP0001542_abnormal_bone_strength | 0.49169903 |
| 138 | MP0008872_abnormal_physiological_respon | 0.48476945 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.48414694 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.48082793 |
| 141 | MP0003631_nervous_system_phenotype | 0.48054040 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.46933504 |
| 143 | MP0003453_abnormal_keratinocyte_physiol | 0.45898939 |
| 144 | MP0005334_abnormal_fat_pad | 0.45587738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.00391147 |
| 2 | Menorrhagia (HP:0000132) | 8.94801374 |
| 3 | Abnormal platelet volume (HP:0011876) | 8.57228290 |
| 4 | Petechiae (HP:0000967) | 8.47057618 |
| 5 | Purpura (HP:0000979) | 8.25817921 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 7.89735345 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.89735345 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.89735345 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 7.71566766 |
| 10 | Glomerulonephritis (HP:0000099) | 7.20878090 |
| 11 | * Epistaxis (HP:0000421) | 6.53899577 |
| 12 | Gingival bleeding (HP:0000225) | 6.49637073 |
| 13 | Arterial tortuosity (HP:0005116) | 5.92174135 |
| 14 | Complement deficiency (HP:0004431) | 5.89803842 |
| 15 | Urethral obstruction (HP:0000796) | 5.46417572 |
| 16 | Spontaneous hematomas (HP:0007420) | 5.22859748 |
| 17 | Vascular tortuosity (HP:0004948) | 5.20488551 |
| 18 | Dysostosis multiplex (HP:0000943) | 5.11968539 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 5.08282534 |
| 20 | J-shaped sella turcica (HP:0002680) | 4.39986232 |
| 21 | Orthostatic hypotension (HP:0001278) | 4.31000497 |
| 22 | Abnormality of complement system (HP:0005339) | 4.18878081 |
| 23 | Progressive neurologic deterioration (HP:0002344) | 4.17961554 |
| 24 | Chronic diarrhea (HP:0002028) | 3.96166101 |
| 25 | Mutism (HP:0002300) | 3.92323886 |
| 26 | Cerebral aneurysm (HP:0004944) | 3.91755611 |
| 27 | Spondylolisthesis (HP:0003302) | 3.90954481 |
| 28 | Aortic aneurysm (HP:0004942) | 3.88106385 |
| 29 | Retinal atrophy (HP:0001105) | 3.83357512 |
| 30 | Hepatosplenomegaly (HP:0001433) | 3.72203988 |
| 31 | Intestinal atresia (HP:0011100) | 3.66420240 |
| 32 | Split foot (HP:0001839) | 3.64730707 |
| 33 | Broad face (HP:0000283) | 3.64431439 |
| 34 | * Impaired platelet aggregation (HP:0003540) | 3.58911166 |
| 35 | * Abnormal platelet function (HP:0011869) | 3.58911166 |
| 36 | Nephritis (HP:0000123) | 3.58505433 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 3.55075895 |
| 38 | Poikilocytosis (HP:0004447) | 3.54892082 |
| 39 | Conjunctival telangiectasia (HP:0000524) | 3.53648141 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.45179039 |
| 41 | Mucopolysacchariduria (HP:0008155) | 3.45179039 |
| 42 | Acanthocytosis (HP:0001927) | 3.41193350 |
| 43 | Dyschromatopsia (HP:0007641) | 3.36489063 |
| 44 | Partial duplication of thumb phalanx (HP:0009944) | 3.36205575 |
| 45 | Obstructive sleep apnea (HP:0002870) | 3.30908571 |
| 46 | Axonal loss (HP:0003447) | 3.25389265 |
| 47 | Hematochezia (HP:0002573) | 3.24177881 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22310979 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22310979 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22310979 |
| 51 | Recurrent abscess formation (HP:0002722) | 3.21870008 |
| 52 | Striae distensae (HP:0001065) | 3.20093143 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.19771424 |
| 54 | Rectovaginal fistula (HP:0000143) | 3.12372235 |
| 55 | Rectal fistula (HP:0100590) | 3.12372235 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 3.07427801 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 3.04961219 |
| 58 | Upper motor neuron abnormality (HP:0002127) | 3.04498649 |
| 59 | Aortic dissection (HP:0002647) | 3.04051359 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 3.02367372 |
| 61 | Intestinal fistula (HP:0100819) | 2.99498891 |
| 62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.99022047 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.98768444 |
| 64 | Cervical subluxation (HP:0003308) | 2.98199881 |
| 65 | * Bruising susceptibility (HP:0000978) | 2.97087162 |
| 66 | Partial duplication of the phalanx of hand (HP:0009999) | 2.92846387 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.81774859 |
| 68 | Lower limb asymmetry (HP:0100559) | 2.78082638 |
| 69 | Colitis (HP:0002583) | 2.77152854 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.76683435 |
| 71 | Amyloidosis (HP:0011034) | 2.74390778 |
| 72 | Vaginal fistula (HP:0004320) | 2.72687682 |
| 73 | Flared iliac wings (HP:0002869) | 2.72495680 |
| 74 | Xanthomatosis (HP:0000991) | 2.68230890 |
| 75 | Deformed sella turcica (HP:0002681) | 2.66990306 |
| 76 | Disinhibition (HP:0000734) | 2.66633057 |
| 77 | Abnormal pupillary function (HP:0007686) | 2.52269450 |
| 78 | Agnosia (HP:0010524) | 2.49583288 |
| 79 | Paralysis (HP:0003470) | 2.47970252 |
| 80 | Increased density of long bones (HP:0006392) | 2.42617499 |
| 81 | Abnormal auditory evoked potentials (HP:0006958) | 2.42369658 |
| 82 | Cardiomegaly (HP:0001640) | 2.42175364 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.35073750 |
| 84 | Abnormality of lateral ventricle (HP:0030047) | 2.33856676 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.33263138 |
| 86 | Arnold-Chiari malformation (HP:0002308) | 2.32841146 |
| 87 | Diplopia (HP:0000651) | 2.32411491 |
| 88 | Abnormality of binocular vision (HP:0011514) | 2.32411491 |
| 89 | Cerebral palsy (HP:0100021) | 2.30676010 |
| 90 | Stomatitis (HP:0010280) | 2.30271229 |
| 91 | Encephalitis (HP:0002383) | 2.28342143 |
| 92 | Mitral stenosis (HP:0001718) | 2.26413725 |
| 93 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.26062142 |
| 94 | Arterial thrombosis (HP:0004420) | 2.19619044 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.19572240 |
| 96 | Abnormality of the sella turcica (HP:0002679) | 2.18723193 |
| 97 | Decreased central vision (HP:0007663) | 2.17231585 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 2.15653218 |
| 99 | Camptodactyly of toe (HP:0001836) | 2.12681160 |
| 100 | Inflammation of the large intestine (HP:0002037) | 2.09586207 |
| 101 | Joint swelling (HP:0001386) | 2.07916914 |
| 102 | Vertigo (HP:0002321) | 2.06255233 |
| 103 | Panhypogammaglobulinemia (HP:0003139) | 2.03004134 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.02933334 |
| 105 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.02933334 |
| 106 | Thoracic kyphosis (HP:0002942) | 2.02785619 |
| 107 | Ventricular fibrillation (HP:0001663) | 2.02701958 |
| 108 | Aortic regurgitation (HP:0001659) | 2.02639077 |
| 109 | Joint hemorrhage (HP:0005261) | 1.99171213 |
| 110 | Tinnitus (HP:0000360) | 1.98930668 |
| 111 | Myocardial infarction (HP:0001658) | 1.94939636 |
| 112 | Erectile abnormalities (HP:0100639) | 1.94364493 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93888919 |
| 114 | Obstructive lung disease (HP:0006536) | 1.93888919 |
| 115 | Spontaneous abortion (HP:0005268) | 1.93478210 |
| 116 | Recurrent skin infections (HP:0001581) | 1.93405545 |
| 117 | Upper limb muscle weakness (HP:0003484) | 1.92584910 |
| 118 | Thick nail (HP:0001805) | 1.92554012 |
| 119 | Urinary incontinence (HP:0000020) | 1.91949374 |
| 120 | Joint stiffness (HP:0001387) | 1.90233033 |
| 121 | Pathologic fracture (HP:0002756) | 1.89523880 |
| 122 | Hypoplasia of the odontoid process (HP:0003311) | 1.88823642 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.87802931 |
| 124 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.87697657 |
| 125 | Gastrointestinal inflammation (HP:0004386) | 1.86460566 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85876569 |
| 127 | Recurrent fungal infections (HP:0002841) | 1.85455174 |
| 128 | Myositis (HP:0100614) | 1.84186519 |
| 129 | Facial diplegia (HP:0001349) | 1.77531733 |
| 130 | Papillary thyroid carcinoma (HP:0002895) | 1.77412967 |
| 131 | Back pain (HP:0003418) | 1.75921738 |
| 132 | Chest pain (HP:0100749) | 1.75565186 |
| 133 | Episodic fever (HP:0001954) | 1.75302735 |
| 134 | Gastrointestinal atresia (HP:0002589) | 1.74850199 |
| 135 | Bladder carcinoma (HP:0002862) | 1.74137845 |
| 136 | Bladder neoplasm (HP:0009725) | 1.74137845 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72589573 |
| 138 | Prolonged bleeding time (HP:0003010) | 1.72479282 |
| 139 | Polygenic inheritance (HP:0010982) | 1.70655908 |
| 140 | Abnormality of the prostate (HP:0008775) | 1.68977990 |
| 141 | Polyphagia (HP:0002591) | 1.68464366 |
| 142 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.67779748 |
| 143 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.67728487 |
| 144 | Anal stenosis (HP:0002025) | 1.67321718 |
| 145 | Orchitis (HP:0100796) | 1.66762044 |
| 146 | Macroglossia (HP:0000158) | 1.66511796 |
| 147 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66258436 |
| 148 | Thickened calvaria (HP:0002684) | 1.64437519 |
| 149 | Increased IgM level (HP:0003496) | 1.63780880 |
| 150 | Postural instability (HP:0002172) | 1.63206692 |
| 151 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62152203 |
| 152 | Osteolytic defects of the hand bones (HP:0009699) | 1.62152203 |
| 153 | Hemiplegia (HP:0002301) | 1.62013685 |
| 154 | Inappropriate behavior (HP:0000719) | 1.61313962 |
| 155 | Nausea (HP:0002018) | 1.60598666 |
| 156 | Biconcave vertebral bodies (HP:0004586) | 1.60437629 |
| 157 | Meningitis (HP:0001287) | 1.60380483 |
| 158 | Abnormality of the odontoid process (HP:0003310) | 1.60070180 |
| 159 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.60061847 |
| 160 | Osteomyelitis (HP:0002754) | 1.59473352 |
| 161 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.58550070 |
| 162 | Leiomyosarcoma (HP:0100243) | 1.57602732 |
| 163 | Uterine leiomyosarcoma (HP:0002891) | 1.57602732 |
| 164 | Increased serum ferritin (HP:0003281) | 1.55769735 |
| 165 | Mediastinal lymphadenopathy (HP:0100721) | 1.55411680 |
| 166 | Leukocytosis (HP:0001974) | 1.55215622 |
| 167 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.55057974 |
| 168 | Dementia (HP:0000726) | 1.53733913 |
| 169 | Peripheral demyelination (HP:0011096) | 1.53518331 |
| 170 | Periauricular skin pits (HP:0100277) | 1.52446018 |
| 171 | Preauricular pit (HP:0004467) | 1.52446018 |
| 172 | Male infertility (HP:0003251) | 1.51374511 |
| 173 | Arthralgia (HP:0002829) | 1.51282982 |
| 174 | Febrile seizures (HP:0002373) | 1.50259819 |
| 175 | Pulmonary embolism (HP:0002204) | 1.49974199 |
| 176 | Agammaglobulinemia (HP:0004432) | 1.49215647 |
| 177 | Distal lower limb amyotrophy (HP:0008944) | 1.47288821 |
| 178 | Thrombocytosis (HP:0001894) | 1.47231835 |
| 179 | Memory impairment (HP:0002354) | 1.45974265 |
| 180 | Mucosal telangiectasiae (HP:0100579) | 1.45653233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 8.65616699 |
| 2 | PDK2 | 5.53015904 |
| 3 | GRK7 | 5.16026791 |
| 4 | BMX | 3.62715900 |
| 5 | MST4 | 3.30488147 |
| 6 | MAPK15 | 2.99740497 |
| 7 | TEC | 2.95334269 |
| 8 | NEK9 | 2.88462733 |
| 9 | BTK | 2.83197037 |
| 10 | CSF1R | 2.75766610 |
| 11 | MOS | 2.48488842 |
| 12 | MYLK | 2.29350487 |
| 13 | MAPK7 | 2.27191861 |
| 14 | TAOK3 | 2.19552112 |
| 15 | STK10 | 2.17567875 |
| 16 | TYK2 | 2.07882005 |
| 17 | GRK5 | 2.06527311 |
| 18 | ARAF | 2.04825221 |
| 19 | CDK8 | 1.95651349 |
| 20 | MAPK12 | 1.90130133 |
| 21 | TNK2 | 1.88852733 |
| 22 | PTK2B | 1.88435078 |
| 23 | FGR | 1.83397694 |
| 24 | NEK6 | 1.78307552 |
| 25 | MATK | 1.75005025 |
| 26 | EIF2AK1 | 1.74077698 |
| 27 | ERN1 | 1.72928076 |
| 28 | RIPK4 | 1.62623187 |
| 29 | TSSK6 | 1.50728442 |
| 30 | TXK | 1.40350241 |
| 31 | JAK1 | 1.31909894 |
| 32 | PKN2 | 1.31355972 |
| 33 | CLK1 | 1.30020716 |
| 34 | PDK1 | 1.25529075 |
| 35 | MAP3K9 | 1.20504916 |
| 36 | JAK3 | 1.18329965 |
| 37 | STK3 | 1.11795422 |
| 38 | KIT | 1.09321509 |
| 39 | GRK6 | 1.06289522 |
| 40 | JAK2 | 1.05904775 |
| 41 | ILK | 1.05768556 |
| 42 | SGK2 | 1.03181939 |
| 43 | ZAP70 | 1.01836435 |
| 44 | IRAK1 | 0.99942430 |
| 45 | RET | 0.98547507 |
| 46 | PNCK | 0.97777955 |
| 47 | IKBKB | 0.95051033 |
| 48 | BLK | 0.92433758 |
| 49 | TBK1 | 0.91879401 |
| 50 | PIM2 | 0.91712398 |
| 51 | MAP4K1 | 0.89784960 |
| 52 | EIF2AK2 | 0.88989011 |
| 53 | PLK2 | 0.86832147 |
| 54 | IRAK4 | 0.85820159 |
| 55 | PAK4 | 0.84449428 |
| 56 | MAP2K1 | 0.83443417 |
| 57 | CAMKK1 | 0.83237509 |
| 58 | MAP3K6 | 0.82610473 |
| 59 | EPHA3 | 0.82267921 |
| 60 | PDGFRB | 0.81174664 |
| 61 | PAK1 | 0.78797301 |
| 62 | ERBB2 | 0.78695808 |
| 63 | MAP3K5 | 0.74118449 |
| 64 | LYN | 0.73641331 |
| 65 | CAMK1D | 0.73112334 |
| 66 | CSK | 0.70902008 |
| 67 | PDPK1 | 0.70248039 |
| 68 | CDK3 | 0.69824732 |
| 69 | NTRK3 | 0.67006282 |
| 70 | STK24 | 0.64731145 |
| 71 | RPS6KA2 | 0.64019789 |
| 72 | YES1 | 0.63596875 |
| 73 | PRKACG | 0.63230685 |
| 74 | PAK2 | 0.62525636 |
| 75 | MAPKAPK5 | 0.62062179 |
| 76 | HCK | 0.61452849 |
| 77 | MAPKAPK3 | 0.60332483 |
| 78 | CDK9 | 0.59072285 |
| 79 | DAPK2 | 0.59061962 |
| 80 | NTRK2 | 0.58208463 |
| 81 | MAPKAPK2 | 0.57825213 |
| 82 | IGF1R | 0.56196287 |
| 83 | ADRBK2 | 0.55970176 |
| 84 | BMPR2 | 0.54869034 |
| 85 | IRAK2 | 0.53802011 |
| 86 | MELK | 0.53566401 |
| 87 | DAPK3 | 0.50507447 |
| 88 | RPS6KL1 | 0.50239243 |
| 89 | RPS6KC1 | 0.50239243 |
| 90 | CAMK4 | 0.49674193 |
| 91 | MAP2K3 | 0.49580608 |
| 92 | ACVR1B | 0.49493756 |
| 93 | TNIK | 0.48999484 |
| 94 | FGFR4 | 0.48600343 |
| 95 | SGK494 | 0.48126368 |
| 96 | SGK223 | 0.48126368 |
| 97 | LCK | 0.47091647 |
| 98 | CAMK1 | 0.46527554 |
| 99 | EEF2K | 0.45980034 |
| 100 | RPS6KA6 | 0.45866643 |
| 101 | PIK3CG | 0.45578866 |
| 102 | FES | 0.43436642 |
| 103 | FER | 0.42975334 |
| 104 | FLT3 | 0.42624238 |
| 105 | MINK1 | 0.42467548 |
| 106 | IKBKE | 0.42040455 |
| 107 | ROCK1 | 0.41914857 |
| 108 | MARK3 | 0.40349591 |
| 109 | PRKAA2 | 0.40085667 |
| 110 | SYK | 0.38816623 |
| 111 | RAF1 | 0.38812588 |
| 112 | FGFR3 | 0.37613808 |
| 113 | CAMK2G | 0.37376899 |
| 114 | CAMK1G | 0.37243029 |
| 115 | PAK3 | 0.37035161 |
| 116 | STK4 | 0.36748648 |
| 117 | ROCK2 | 0.36595315 |
| 118 | CDK6 | 0.36453124 |
| 119 | MAP3K7 | 0.36426244 |
| 120 | EPHB2 | 0.35589961 |
| 121 | ITK | 0.34840677 |
| 122 | MARK2 | 0.34469672 |
| 123 | MAPK13 | 0.34420241 |
| 124 | CDC42BPA | 0.33270660 |
| 125 | RPS6KA4 | 0.32723957 |
| 126 | PRKCD | 0.32570176 |
| 127 | LMTK2 | 0.31593937 |
| 128 | PRKG1 | 0.31442011 |
| 129 | MAP3K1 | 0.30999004 |
| 130 | SIK2 | 0.30710666 |
| 131 | KSR2 | 0.30537904 |
| 132 | CAMKK2 | 0.30400588 |
| 133 | MAP3K14 | 0.29556504 |
| 134 | PKN1 | 0.29169398 |
| 135 | TRIB3 | 0.27689676 |
| 136 | EGFR | 0.27480716 |
| 137 | SGK3 | 0.26881972 |
| 138 | MAPK4 | 0.25899227 |
| 139 | INSR | 0.24991205 |
| 140 | PTK6 | 0.23834723 |
| 141 | MAP2K2 | 0.23495257 |
| 142 | VRK1 | 0.23420201 |
| 143 | EPHB1 | 0.22533167 |
| 144 | GSK3A | 0.20739689 |
| 145 | TGFBR1 | 0.17928080 |
| 146 | MAP2K4 | 0.17785171 |
| 147 | INSRR | 0.16015457 |
| 148 | ADRBK1 | 0.15774552 |
| 149 | PDGFRA | 0.14910877 |
| 150 | HIPK2 | 0.14279967 |
| 151 | PRKD1 | 0.14247266 |
| 152 | FYN | 0.12607132 |
| 153 | MAP2K6 | 0.12285656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 5.41392201 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.98612716 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.89635087 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 4.76531893 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.48486543 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.91730301 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.34081270 |
| 8 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.21668741 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04198039 |
| 10 | Prion diseases_Homo sapiens_hsa05020 | 1.87300927 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81894692 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.78337064 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76207682 |
| 14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.74223148 |
| 15 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.55751405 |
| 16 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.46420989 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.45557533 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.45288170 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41894399 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.32995659 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30133052 |
| 22 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27079604 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26494027 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25965364 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21907608 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19957485 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16996323 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14825246 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14178237 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14067096 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12405229 |
| 32 | Morphine addiction_Homo sapiens_hsa05032 | 1.12084121 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11535759 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11510657 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.11033010 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06184929 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02647392 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.01828501 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00912665 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99080598 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97826776 |
| 42 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95899683 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93207937 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 0.93108235 |
| 45 | * Platelet activation_Homo sapiens_hsa04611 | 0.92181524 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90982151 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88081711 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87049485 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86502167 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.84985724 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84535862 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.83422081 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83270878 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.82847465 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82331008 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77269343 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76809914 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.76080539 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73973384 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67175025 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66902282 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66285971 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66020042 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65889700 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65231105 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64478507 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64419823 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63349518 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62743595 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62145005 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62096319 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.60078281 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59948275 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.59014187 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58648812 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58283969 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57413946 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56948468 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55885440 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.55754478 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55418990 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.55117441 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54786219 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53535231 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.53357193 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53133003 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52839969 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52450932 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.51404223 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51113589 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.49190260 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.49063476 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48533874 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48372070 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47630336 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47213204 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46996258 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46622252 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46360881 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45522223 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.45025668 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44332219 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44178163 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43252775 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42989263 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42717150 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41998499 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39842077 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39817281 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.38961196 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38910905 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38411649 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38041479 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.36235464 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35906009 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35539481 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35072674 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33502227 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32160633 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.32144279 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31762342 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.30541166 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.28242263 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27313567 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27229032 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.27016725 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26988680 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26485174 |
| 129 | Malaria_Homo sapiens_hsa05144 | 0.25024863 |
| 130 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.24656901 |
| 131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.24565811 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22824980 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22821916 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.21828796 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21628279 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20910635 |
| 137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.20494345 |

